Vaccines | Free Full-Text | Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants - discu.eu

Reddit

E. coli bacteria can be used to create low cost COVID vaccines. A study on mice using a novel liposomal adjuvant shows the vaccine induced polyclonal antibodies in vitro, and potently neutralized homologous and heterologous SARS-CoV-2 pseudoviruses. https://www.mdpi.com/2076-393X/11/1/42 13 comments 26/12/2022 science

Linked pages

Association of COVID-19 Vaccination with Risk of Medically-Attended Post-Acute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras | Open Forum Infectious Diseases | Oxford Academic https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab358/6316214 179 comments
Creative Commons — Attribution 4.0 International — CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ 95 comments

Related searches:

Search whole site: site:www.mdpi.com

Search title: Vaccines | Free Full-Text | Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants

See how to search.

Submit link to: